The big biopharma company Biogen seems poised for an upside pop soon based on recent turnover and bullish price divergence. Back in April, the stock took a major tumble of more than 20% on heavy turnover. It now appears to have bottomed out. It made a nice morningstar pattern (circled) and a higher low on the chart. What I really find intriguing is the bullish turn on money flow (bottom pane). In April that was not a positive sign, so this is an important divergence.

The bullish candle on June 19 filled the nasty gap down from the prior week. At this point, Biogen has a good chance to reach the 200 ma for the first time since breaking down in late April. I think it is likely to follow the yellow dotted lines. MACD has also held positive, so we are bullish on this name to at least reach the breakdown level in April.